Czapska, M., Babkiewicz, K., Pabis, S. and Skórzyńska-Dziduszko, K. 2018. Sotagliflozin, an inhibitor of sodium–glucose cotransporters 1 and 2 (SGLT1/2), as a new therapeutic approach for patients with type 1 diabetes mellitus. Journal of Education, Health and Sport. 8, 12 (Dec. 2018), 335–351.